Aptevo Therapeutics Inc. (APVO) vs CollPlant Biotechnologies Ltd. (CLGN)
A side-by-side comparison of Aptevo Therapeutics Inc. and CollPlant Biotechnologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APVO
Aptevo Therapeutics Inc.
$1.81HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
CLGN
CollPlant Biotechnologies Ltd.
$3.34HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
Total return — APVO vs CLGN
growth of $100 · dividends reinvested · last 9yAPVO -100.0% (-84.1%/yr)CLGN -96.2% (-30.5%/yr)CLGN compounded faster over this window
Log scale — wide-divergence pair
APVO CLGN
APVO vs CLGN: by the numbers
- •CLGN is the larger company ($4M vs $4M market cap).
- •Both run net losses; APVO's is the smaller (0.00% vs -3934.91% net margin).
Metrics side by side
Valuation
| Metric | APVO | CLGN |
|---|---|---|
| P/S ratio | N/A | 13.60 |
| P/B ratio | 0.66 | 1.47 |
Profitability
| Metric | APVO | CLGN |
|---|---|---|
| Gross margin | 0.00% | 26.32% |
| Operating margin | 0.00% | -484.31% |
| Net margin | 0.00% | -3934.91% |
| ROE | -437.15% | -424.89% |
| ROIC | -288.14% | -221.32% |
Growth (annualized)
| Metric | APVO | CLGN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -56.28% |
| Total return CAGR (5Y) | -95.30% | -53.69% |
Frequently asked
- How have APVO and CLGN total returns compared?
- Over the past 5 years, APVO delivered -95.30% and CLGN delivered -53.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.